Guru Ownership Trend
Guru Analysis for Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. (ANIK), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $12.13 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $3.34 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 47.5%. Conversely, Cliff Asness reduced exposure by 28.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for Anika Therapeutics, Inc. (ANIK)
Major holders include Renaissance Technologies (RenTech) ($9.02 M), Cliff Asness ($7.88 M), Paul Tudor Jones ($662,208). According to the latest reported data, 4 tracked investment managers collectively hold approximately 916,525 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $3.34 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited ANIK. The total reported sell value was $3.57 M.
Yes, 0 managers opened new positions in ANIK, and 2 increased their existing holdings. The total reported buy value was $225,500.28.